References

Mental Health Statistics: The Most Common Mental Health Problems (Internet) 2017. https://www.mentalhealth.org.uk/statistics/mental-health-statistics-most-common-mental-health-problems (Cited: December 2017)
World Health Organization. Depression (Internet) 2017. http://www.who.int/mediacentre/factsheets/fs369/en/ (Cited December 2017)
Oral Health Factsheet for Dental Professionals: Adults with Depression.Washington: School of Dentistry, University of Washington; 2011
Reese R. Depression and dental health. Clinical update.: Naval Postgraduate Dental School, National Naval Dental Center, Bethesda, Maryland; 2003
Warren KR, Postolache TT, Groer ME, Pinjari O, Kelly DL, Reynolds M. Role of chronic stress and depression in periodontal diseases. Periodontology 2000. 2014; 64:127-138
Suresh K, Shenai P, Chatra L, Ronad Y-AA, Bilahari N, Pramod RC Oral mucosal diseases in anxiety and depression patients: hospital based observational study from South India. J Clin Exp Dent. 2015; 7::e95-e99
Suresh KV, Ganiger CC, Ahammed YAR, Kumar MCD, Pramod RC, Nayak AG Psychosocial characteristics of oromucosal diseases in psychiatric patients: observational study from Indian Dental College. N Am J Med Sci. 2014; 6:570-574
Malik R, Goel S, Misra D, Panjwani S, Misra A. Assessment of anxiety and depression in patients with burning mouth syndrome: a clinical trial. J Midlife Health. 2012; 3:36-39
Kalkur C, Sattur AP, Guttal KS. Role of depression, anxiety and stress in patients with oral lichen planus: a pilot study. Indian J Dermatol. 2015; 60:445-449
Sutin AR, Terracciano A, Ferrucci L, Costa PT. Teeth grinding: is emotional stability related to bruxism?. J Res Pers. 2010; 44:402-405
Ameida PDV, Johann ACBR, Alanis LR, Lima AAS, Grégio AMT. Antidepressants: side effects in the mouth. Oral Health Care-Pediatr Res Epidemiol Clin Pract. 2012; 6:113-128
Dumitrescu A. Depression and inflammatory periodontal disease considerations – an interdisciplinary approach. Front Psychol. 2016; 7 https://doi.org/10.3389/fpsyg.2016.00347
Araujo MM, Martins CC, Costa LCM, Cota LOM, Faria RLAM, Cunha FA Association between depression and periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016; 43:216-228
Haq MW, Tanwir F, Tabassum S, Nawaz M, Siddiqui MF. Association of periodontitis and systemic diseases. Int J Dent Oral Health. 2015; 1.1:1-7
Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontology 2000. 2002; 29:177-206
Grossarth-Maticek R, Eysenck HJ. Personality, smoking, and alcohol as synergistic risk factors for cancer of the mouth and pharynx. Psychol Rep. 1990; 67:(3 Pt 1)1024-1036
Lages EJP, Costa FO, Cortelli SC, Cortelli JR, Cota LOM, Cyrino EM Alcohol consumption and periodontitis: quantification of periodontal pathogens and cytokines. J Periodontol. 2015; 86:1058-1068
Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003; 20:64-77
Cortelli JR, Barbosa MDS, Westphal MA. Halitosis: a review of associated factors and therapeutic approach. Braz Oral Res. 2008; 22:44-54
Bollen CML, Beikler T. Halitosis: the multidisciplinary approach. Int J Oral Sci. 2012; 4:55-63
Saintrain MVL, Souza EHA. Impact of tooth loss on the quality of life. Gerodontology. 2012; 29:e632-e636
Chapple ILC, Genco R Diabetes and Periodontal Diseases: Consensus Report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013; 40:S106-S112
Mawardi HH, Elbadawi LS, Sonis ST. Current understanding of the relationship between periodontal and systemic diseases. Saudi Med J. 2015; 36:150-158
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370:(9590)851-858
Mazumdar U, Mazumdar B, Arya G, Rajkumar IR. Gingivitis artefacta – self injurious behaviour in adult patients of depression report of 2 cases. J Orofacial Res. 2011; 1:45-48
Pattnaik N, Satpathy A, Mohanty R, Nayak R, Sahoo S. Interdisciplinary management of gingivitis artefacta major: a case series. Case Rep Dent. 2015; 2015
Korszun A, Hinderstein B, Wong M, Peterson LJ. Comorbidity of depression with chronic facial pain and temporomandibular disorders. Oral Surg Oral Med Oral Path Oral Radiol Endod. 1996; 82:496-500

The oral implications of mental health disorders part 2: depression

From Volume 46, Issue 2, February 2019 | Pages 119-124

Authors

Nisma Patel

BDS, MFDS RCS (Edin), PgCert Med Ed

Specialty Dentist (Oral Surgery), Oral Surgery Department, Guy's and St Thomas' NHS Foundation Trust, London

Articles by Nisma Patel

Michael Milward

Lecturer in Periodontology and Senior Lecturer in Molecular Biology, Birmingham Dental School, Birmingham, B4 6NN, UK

Articles by Michael Milward

Abstract

Abstract: This is the second of two articles that look at the oral manifestations of mental health disorders. Part 1 focused on eating disorders, covering anorexia nervosa, bulimia nervosa and binge eating disorder. It explained each condition, common associated habits and explored the possible oral signs and symptoms that may present. Part 2 concentrates on depression and its significant effect on the oral cavity. These articles aim to increase awareness of mental health disorders and highlight the importance of dental practitioners being able to recognize oral signs and symptoms of eating disorders so that appropriate referrals can be made.

CPD/Clinical Relevance: Depression is an increasingly common affliction and therefore it is important for dental professionals to recognize the associated oral manifestations. An improved awareness of the condition and possible symptoms can aid diagnosis and appropriate management.

Article

Depression

Depression is a common mental health disorder affecting 4−10% of people in England and approximately 300 million people globally.1, 2 It is a psychiatric disorder characterized by low mood and can include feelings of sadness, despair or discouragement. It can often involve loss of interest in usual activities, social withdrawal and somatic symptoms, including sleep and appetite disturbance.3, 4 In order to arrive at a diagnosis of depression, the altered behaviour must persist for a minimum of two weeks.4 Chronic stress is strongly associated with depression, with a possible causal relationship between stressful life events and major depressive episodes. The neurobiology underlying stress and depression is thought to result from molecular and cellular abnormalities that interact with genetic and environmental factors.5 It is essential for dental professionals to understand and recognize the possible oral manifestations of depression. This knowledge can help undiagnosed patients receive an appropriate early referral to a medical practitioner, and will also be of benefit in managing the oral manifestations of this disease.

Mucosal lesions

The oral tissues are highly responsive to psychological influences; thus it has been suggested that psychological disturbance can compromise oral health. Psychological factors can alter the markers of the nervous system (catecholamines: adrenaline, noradrenaline and dopamine), endocrine system (cortical and aldosterone) and immune system (T-cells, B-cells and NK-cells), which in turn can lead to oral disease pathogenesis.6, 7 This interaction between psychological and biological systems increases the prevalence of conditions such as burning mouth syndrome (BMS), oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS) in patients with depression.6

The aetiology of BMS is thought to be largely neuropathic. BMS has a strong psychological relationship with anxiety and stress, and a high number of patients with BMS are reported to suffer from moderate to severe depression. Patients with depression may encounter burning mouth symptoms as either a consequence of xerostomia or as a side-effect of antidepressant medication.8 Furthermore, prolonged psychosocial and emotive stress may contribute to the initiation and clinical expression of OLP. These factors may also precipitate in the transformation of reticular OLP to the erosive form.9 Individuals with moderate and severe depression are likely to exhibit a higher incidence of RAS compared to patients with mild depression.6

Dental lesions

Individuals with depression often have little interest or motivation to maintain adequate self-care activities, which can adversely affect oral hygiene and compliance with treatment. Poor oral hygiene may result in an increased incidence of dental caries. The risk of dental caries formation may be exacerbated further by a cariogenic diet. Patients with depression have a suppressed serotonin metabolism, which can lead to an increased preference for carbohydrates. This creates conditions favourable for the growth of aciduric bacteria.3, 4 Ineffective biofilm disruption associated with poor oral hygiene can allow the aciduric bacteria to colonize and multiply.4 Drug-induced xerostomia is a common side-effect of antidepressant medication, which can also facilitate the formation of dental caries due to reduced salivary flow and compromised buffering action.3, 4

Patients with depression are more likely to exhibit signs of bruxism because parafunctional activity is a physical manifestation of emotional stress and anxiety.10 In addition, bruxism can be experienced by patients taking anti-depressants because these drugs raise extrapyramidal serotonin levels, thus inhibiting the dopaminergic pathways that control these movements.3, 11 Chronic bruxism can lead to severe tooth wear and dentine hypersensitivity (Figure 1). Myofascial pain and temporomandibular joint disorders may also arise due to parafunctional activity.10

Figure 1. Significant non-carious tooth tissue loss resulting from attrition (bruxism) and erosion (acidic/alcoholic beverages).

Periodontal lesions

There is evidence that a bi-directional relationship exists between depression and periodontal disease, with multiple pathways linking the two (Figure 2).12 The different mechanisms proposed for the effect of depression on periodontal health include dysregulation of the hypothalamic-pituitary-adrenal (HPA) system, behavioural changes and anti-depressive medication.5, 12 Each mechanism can independently induce periodontal destruction, however their combination may interact to magnify the effect.12

Figure 2. Diagram showing the potential relationship between depression and periodontal tissue breakdown. Depression can contribute to periodontal tissue breakdown via a dysregulated hypothalamic-pituitary-adrenal response axis, behavioural changes and anti-depressive medication. Periodontal disease itself may lead to depression by generating systemic inflammation and from psychosocial affects such as halitosis and tooth loss which impact on self-esteem and confidence. There is an indirect link between periodontal tissue breakdown and depression via associated systemic disease such as diabetes mellitus and cardiovascular disease. Adapted from Dumitrescu.12

Depression can lead to biological changes within the body, including dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. Stress mediators, including monoamines, neuropeptides and steroid hormones, convey stress signals to the central nervous system and in turn this affects the HPA axis. This will cause a shift in cortisol balance, which results in compromised immune defences and excessive secretion of pro-inflammatory cytokines. These pro-inflammatory cytokines include interleukin-1beta (IL-1β), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α).5 Through these processes, depression might affect progression of periodontal infection in susceptible patients and may compromise treatment outcome through delayed wound healing.12 The biological effect of stress on the body and its potential progression to periodontal disease is depicted in Figure 3.5 Behavioural changes that may occur in patients with depression include poorer oral hygiene, increased smoking and excessive alcohol consumption.12, 13 Negligence for oral hygiene can result in plaque and calculus accumulation, which can lead to gingivitis and an increased risk of developing periodontitis.3, 4, 14 A dose-effect relationship exists between cigarette smoking and severity of periodontal disease, highlighting its significant effect on periodontal destruction. Smoking causes both functional impairment in gingival microcirculation and structural changes within fibroblasts. Also, it can have a significant effect on the immune system, modifying the humoral and cellular immune systems and affecting the cytokine and adhesion molecule network.15 Moreover, increased alcohol consumption is often associated with depression and this has the potential to lead to alcohol dependence. Evidence shows the combined interaction of alcohol and smoking has a synergistic effect in the development of oral and pharyngeal cancers.16 Excessive alcohol consumption can also alter host immune responses, increasing susceptibility to micro-organisms. Alcohol can increase both the prevalence and severity of periodontitis, with a positive correlation existing between attachment loss and alcohol consumption. This occurs as alcohol can cause oral dehydration and reduced salivary flow, therefore high alcohol consumption can contribute to an increased rate of biofilm formation and accumulation.17 The effect of these behavioural changes on the periodontium can be exacerbated by drug-induced xerostomia. Saliva is more viscous in patients with xerostomia, resulting in enhanced food and bacteria adherence to teeth and consequent plaque accumulation, which may ultimately contribute to periodontal disease.18

Figure 3. Diagram illustrating the influence of chronic stress on the body. Significant stress can cause activation of the central nervous system and lead to depressed immune function through the HPA axis. A suppressed immune system can increase susceptibility to infections and development of diseases, such as periodontitis.5

The concept that periodontal disease may influence the onset of depression is based upon a cell-mediated response to the periodontal pathogens, leading to chronic, low-grade inflammation. Patients with depression often have increased oxidative and nitrosative stress, which contributes to the neuro-progression of this condition. It is also common for these patients to have increased serum levels of both pro-inflammatory cytokines and acute phase proteins. The pro-inflammatory cytokines include IL-1, IL-6 and TNFα and the acute phase proteins are C-reactive proteins (CRP), complement factors and chemokines. Periodontal disease is also associated with high levels of systemic inflammation, particularly IL-6, TNF-α and CRP. These may potentiate oxidative and nitrosative stress and inflammatory processes, which may consequently lead to an increased susceptibility of depression.12

Patients with periodontal disease may also be more likely to experience depression through psychological effects of tooth loss and complications such as halitosis, both of which may arise as a consequence of periodontits.12 Halitosis, which may be related to oral neglect and periodontal disease, may lead to embarrassment causing personal and social isolation.19, 20 Tooth loss may impair masticatory function which can affect nutritional status. It can also have a major impact on aesthetics, significantly affecting self-esteem and confidence.12, 21 Periodontal disease can have a detrimental effect on quality of life and well-being which, if severe, could potentially lead to depression.

Tooth loss has a significant influence on quality of life, especially when it affects well-being, appearance and nutritional status. Periodontal disease may also relate to depression through the shared common factor of systemic disease. There is significant literature suggesting an association between periodontitis and systemic diseases, such as cardiovascular disease and diabetes.17, 22, 23 In addition, epidemiologic studies provide strong evidence that chronic psychosocial stress and depression increase the risk of atherosclerotic cardiovascular disease, diabetes and other systemic conditions, as well as adversely affecting the course and outcome of the conditions.5, 24 This suggests that there may be a relationship between periodontal disease and depression, which is indirectly linked by systemic disease.

Gingivitis artefacta is a type of periodontal disease that is caused by habitual injury to the gingival tissues, resulting in localized recession defects. The condition is usually associated with an emotional disorder, such as depression, and has a higher occurrence in children and females. The self-inflicted injury often involves scratching or picking at the gingiva with a fingernail or any foreign object.25 Appropriate diagnosis of the lesion can often be difficult as the clinical presentation can mimic that of a number of more common causative factors associated with recession defects.26

Other oral symptoms

Xerostomia, as previously indicated, is a common oral side-effect in patients taking anti-depressant medication. Table 1 lists commonly prescribed anti-depressant medications and their associated side-effects.3, 4, 11 Anti-depressants have either anticholinergic or antimuscarinic action, which suppress the parasympathetic nervous system and will inhibit the effects of acetylcholine on the salivary gland receptors. Adrenergic sympathetic vasoconstriction reduces blood flow to the salivary gland, thus reducing salivary flow. The drugs may also interfere with acinar and salivary duct function, resulting in changes to both salivary flow rates and composition.11 These changes to saliva secretion can lead to other oral symptoms including dysgeusia and stomatitis.11


Medication Side-Effects
Selective Serotonin Reuptake Inhibitor (SSRIs), egCitalopramFluoxetineParoxetineSertraline Xerostomia, dysgeusia, stomatitis, gingivitis, glossitis, bruxism, discoloured tongue
Serotonin – Norepinephrine Reuptake Inhibitor, egDuloxetineVenlafaxine Xerostomia, dysphagia, nausea, anxiety, dizziness, nervousness, headache, sweating, bruxism
Norepinephrine – Dopamine ReuptakeInhibitor, egBupropion Xerostomia, dysgeusia, stomatitis, gingivitis, glossitis, bruxism, dysphagia, angioedema
Tricyclic Anti-depressants, egAmitriptylineDesipramineImipramineNortriptyline Xerostomia, sialadenitis, dysgeusia, stomatitis, tongue oedema, tongue discoloration
Monoamine Oxidase Inhibitors, egPhenelzineTranylcypromine Xerostomia

Chronic facial pain and depressive disorders share common pathophysiological characteristics and a comorbidity between these conditions frequently exists.4, 27 A major life event, such as divorce or bereavement, often precedes onset of chronic facial pain by up to 6 months. This type of life stressor has also been implicated in increasing the risk of a major depressive episode. Chronic facial pain and depression have a similar epidemiological background, with a peak prevalence in younger women and a lower incidence in older age groups. Therefore, due to this relationship between these conditions, depression should be considered in patients experiencing chronic facial pain.27

Conclusion/Management in the dental setting

It is important for dental professionals to explain the benefit of good oral hygiene to patients, both in preventing dental caries and periodontitis. Similarly, appropriate dietary advice should be offered, reducing sugar and carbohydrate intake. This should be common practice to all patients, however it may need to be emphasized and monitored in patients with depression.

Additionally, dental professionals need to ensure that they regularly ask their patients about their perceived stress levels. This could be attained by the use of a simple 1−10 scale, with 0 representing no stress and 10 maximum stress. Stress levels are important to document as they may have an impact on the immune system, particularly if not adequately managed. They may also indicate likelihood of compliance with behavioural changes, such as improving oral hygiene or smoking cessation. Patients with high stress levels or those struggling to cope with stress may benefit from referral to their medical practitioner. A medical practitioner may provide support to manage stress and assess whether the patient is suffering with an underlying mental health disorder. The medical management of depression can involve either non-pharmacological or pharmacological treatments.

It is always essential for a thorough medical history to be taken, recording all medications and being aware of possible oral side-effects. Drug-induced xerostomia is a common side-effect of anti-depressants, which can be managed appropriately if identified. Sugar-free gum and lozenges can be recommended to patients to stimulate saliva production or artificial saliva substitutes can be offered. Improving salivary flow may also help patients experiencing burning mouth symptoms. Fluoride supplements can be offered in caries management.3 Finally, occlusal assessment and appropriate management is important for patients exhibiting bruxism and chronic facial pain. These patients may benefit from the use of a hard occlusal guard to relieve masticatory muscle tenderness and avoid further tooth wear.